Yazar "Yılmaz, Yusuf" için listeleme
-
Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: A call for action
Kamani, Lubna; Rahat, Adeel; Yılmaz, Yusuf (Kare Publishing, 2024)The term metabolic dysfunction-associated steatotic liver disease (MASLD), which evolved from its predecessor, nonalcoholic fatty liver disease (NAFLD),[1] -
Asia-Pacific association for study of liver guidelines on management of ascites in liver disease
Singh, Virendra; De, Arka; Mehtani, Rohit; Angeli, Paolo; Maiwall, Rakhi; Satapathy, Sanjaya; Singal, Ashwini K.; Saraya, Anoop; Sharma, B. C.; Eapen, C. E.; Rao, P. N.; Shukla, Akash; Shalimar; Choudhary, Narendra S.; Alcantara-Payawal, Diana; Arora, Vinod; Aithal, Guru; Kulkarni, Anand; Roy, Akash; Shrestha, Ananta; al Mahtab, Mamun; Niriella, Madunil A.; Siam, Tan Soek; Zhang, Chun-Qing; Huei, Lee Guan; Yu, Ming-Lung; Roberts, Stuart K.; Peng, Cheng-Yuan; Chen, Tao; George, Jacob; Wong, Vincent; Yılmaz, Yusuf; Treeprasertsuk, Sombat; Kurniawan, Juferdy; Kim, Seung Up; Younossi, Zobair M.; Sarin, Shiv Kumar (Springer, 2023)The development of ascites is a landmark event in the natural history of cirrhosis. -
Association of metabolic dysfunction-associated fatty liver disease with cognitive impairment and all-cause dementia: A comprehensive review
Kaya, Eda; Yılmaz, Yusuf (AVES, 2024)Metabolic dysfunction-associated fatty liver disease (MAFLD) is a significant public health concern, affecting one-third of the global population and posing a risk for progressive liver disease. MAFLD is characterized by ... -
Brushing your teeth may be good for your liver: Linking oral health to non-alcoholic fatty liver disease
Yılmaz, Yusuf (Elsevier, 2023)he study by Pischke et al. [1], which explores the relationships between non-alcoholic steatohepatitis (NASH) and periodontitis, warrants commendation. The analysis involved 32 patients with NASH and 100 randomly, ... -
Can frequent toothbrushing reduce the risk of cirrhosis among patients with non-alcoholic fatty liver disease? Hints from a registry-based study
Keklikkıran, Çağlayan; Stepanova, Maria; Younossi, Zobair; Yılmaz, Yusuf (Karger, 2023)Introduction: While poor oral hygiene has been previously associated with an increased risk of non-alcoholic fatty liver disease (NAFLD), its association with hepatic fibrosis remains unclear. Here, we sought to analyze ... -
Changes in the etiology of chronic liver disease by referral to a FibroScan center: Increasing prevalence of the nonalcoholic fatty liver disease
Eriş, Tansu; Hassan, Moomen; Hikal, Yousra; Sawah, Enas; Daneshgar, Fatemeh; Teker, Ayşe Gülşen; Özel, Furkan; Lüleci, Nimet Emel; Kaya, Eda; Yılmaz, Yusuf (Kare Publishing, 2023)Background and Aim: Chronic liver disease (CLD) is a leading cause of morbidity and mortality worldwide with a wide etiological spectrum. Fi-broScan (R) is used for follow-up of fibrosis and steatosis. This single -cen-ter ... -
Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
Sakallı Kanı, Ayşe; Özercan, Ahmet; Kanı, Haluk Tarık; Eren, Fatih; Sayar, Kemal; Yılmaz, Yusuf (Kare Publishing, 2023)Background and Aim: Our primary objective is to examine the variance in chronotype, night-eating patterns, and sleep quality in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease. In ... -
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry (TM)
Younossi, Zobair M.; Yu, Ming-Lung; Yılmaz, Yusuf; Alswat, Khalid Aida; Buti, Maria; Fernandez, Marlen Ivon Castellanos; Papatheodoridis, Georgios; Hamid, Saeed S.; El-Kassas, Mohamed; Chan, Wah Kheong; Duseja, Ajay K.; Gordon, Stuart C.; Eguchi, Yuichiro; Isakov, Vasily A.; Roberts, Stuart K.; Fan, Jian-Gao; Singal, Ashwani K.; Romero-Gomez, Manuel; Ahmed, Aijaz; Ong, Janus; Lam, Brian P.; Younossi, Issah; Nader, Fatema; Racila, Andrei; Stepanova, Maria; Alqahtani, Saleh (Wiley, 2023)Chronic hepatitis B (CHB) infection is one of the most common causes of cirrhosis and liver cancer worldwide. Our aim was to assess clinical and patient-reported outcome (PRO) profile of CHB patients from different regions ... -
Deciphering the implications of MAFLD and MASLD definitions in the NAFLD population: Results from a single-center biopsy study
Kaya, Eda; Yılmaz, Yusuf (Wolters Kluwer Medknow Publications, 2024)To the Editor: The nomenclature for steatotic liver disease has been a topic of debate since 2020. The conventional expression, non-alcoholic fatty liver disease (NAFLD), was introduced in 1980 to describe the occurrence ... -
Editorial: "being normal weight each day keeps NAFLD and fibrosis away"-the importance of reducing cumulative exposure to overweight
Yılmaz, Yusuf (Wiley, 2023)The obesity epidemic is globally driving the increased prevalence of non-alcoholic fatty liver disease (NAFLD), and the vast majority of patients with NAFLD are either overweight or obese. -
Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply
Yılmaz, Yusuf; Younossi, Zobair (Wiley, 2023)We appreciate the editorial comments by Drs. Sun and Fan about our study assessing the associations of patient-reported outcomes (PROs) and non-invasive tests (NITs) in patients with non-alcoholic fatty liver disease (NAFLD) ... -
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores
Sanyal, Arun J.; Foucquier, Julie; Younossi, Zobair M.; Harrison, Stephen A.; Newsome, Philip N.; Chan, Wah-Kheong; Yılmaz, Yusuf; De Ledinghen, Victor; Costentin, Charlotte; Zheng, Ming-Hua; Wai-Sun Wong, Vincent; Elkhashab, Magdy; Huss, Ryan S.; Myers, Robert P.; Roux, Marine; Labourdette, Aymeric; Destro, Marie; Fournier-Poizat, Céline; Miette, Véronique; Sandrin, Laurent; Boursier, Jérôme (Elsevier, 2022)Background & Aims: Currently available non-invasive tests, including fibrosis-4 index (FIB-4) and liver stiffness measurement (LSM by VCTE), are highly effective at excluding advanced fibrosis (AF) (F ≥3) or cirrhosis in ... -
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
Kaya, Eda; Yılmaz, Yusuf (Sage Publications, 2022)Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the most common chronic liver disease worldwide – with an estimated global prevalence of 37%. Different from nonalcoholic fatty liver disease (NAFLD), which ... -
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement
Hagstrom, Hannes; Adams, Leon A.; Allen, Alina M.; Byrne, Christopher D.; Chang, Yoosoo; Duseja, Ajay; Gronbaek, Henning; Ismail, Mona H.; Jepsen, Peter; Kanwal, Fasiha; Kramer, Jennifer; Loomba, Rohit; Mark, Henry E.; Newsome, Philip N.; Rinella, Mary E.; Rowe, Ian A.; Ryu, Seungho; Sanyal, Arun; Schattenberg, Joern M.; Serper, Marina; Sheron, Nick; Simon, Tracey G.; Spearman, C. Wendy; Tapper, Elliot B.; Villota-Rivas, Marcela; Wild, Sarah H.; Wong, Vincent Wai-Sun; Yılmaz, Yusuf; Zelber-Sagi, Shira; Aberg, Fredrik; Lazarus, Jeffrey V. (Wiley, 2024)Background:Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research and ... -
Geographical similarity and differences in the burden and genetic predisposition of NAFLD
Yip, Terry Cheuk-Fung; Vilar-Gomez, Eduardo; Petta, Salvatore; Yılmaz, Yusuf; Wong, Grace Lai-Hung; Adams, Leon A.; de Ledinghen, Victor; Sookoian, Silvia; Wong, Vincent Wai-Sun (Wiley, 2022)NAFLD has become a major public health problem for more than 2 decades with a growing prevalence in parallel with the epidemic of obesity and type 2 diabetes (T2D). The disease burden of NAFLD differs across geographical ... -
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
Younossi, Zobair M.; Alqahtani, Saleh A.; Alswat, Khalid; Yılmaz, Yusuf; Keklikkıran, Çağlayan; Funuyet-Salas, Jesús; Romero-Gómez, Manuel; Fan, Jian-Gao; Zheng, Ming-Hua; El-Kassas, Mohamed; Castera, Laurent; Liu, Chun-Jen; Wai-Sun Wong, Vincent; Zelber-Sagi, Shira; Allen, Alina M.; Lam, Brian; Treeprasertsuk, Sombat; Hameed, Saeed; Takahashi, Hirokazu; Kawaguchi, Takumi; Schattenberg, Jörn M.; Duseja, Ajay; Newsome, Phil N.; Francque, Sven; Spearman, C. Wendy; Castellanos Fernández, Marlen I.; Burra, Patrizia; Roberts, Stuart K.; Chan, Wah-Kheong; Arrese, Marco; Silva, Marcelo; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart; Fuchs, Michael; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Eskridge, Wayne; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Yu, Ming-Lung; Gerber, Lynn; Fornaresio, Lisa; Nader, Fatema; Henry, Linda; Racila, Andrei; Golabi, Pegah; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey V. (Elsevier, 2023)Background & Aims: Patients with fatty liver disease may experience stigma from the disease or comorbidities. In this crosssectional study, we aimed to understand stigma among patients with nonalcoholic fatty liver disease ... -
The heated debate over NAFLD renaming: An ongoing saga
Yılmaz, Yusuf (Kare Publishing, 2023)In 1980, Jurgen Ludwig, a pathologist at the Mayo Clinic, and colleagues formally described a disorder that involved the accumulation of fat in the liver, independent of significant alcohol consumption, or other secondary ... -
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
Zhang, Huai; Rios, Rafael S.; Boursier, Jerome; Anty, Rodolphe; Chan, Wah-Kheong; George, Jacob; Yılmaz, Yusuf; Wong, Vincent Wai-Sun; Fan, Jiangao; Dufour, Jean-Francois; Papatheodoridis, George; Chen, Li; Schattenberg, Joern M; Shi, Junping; Xu, Liang; Wong, Grace Lai-Hung; Lange, Naomi F.; Papatheodoridi, Margarita; Mi, Yuqiang; Zhou, Yujie; Byrne, Christopher D.; Targher, Giovanni; Feng, Gong; Zheng, Minghua (Lippincott Williams & Wilkins, 2023)Background:Liver biopsy for the diagnosis of non-alcoholic steatohepatitis (NASH) is limited by its inherent invasiveness and possible sampling errors. Some studies have shown that cytokeratin-18 (CK-18) concentrations may ... -
Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study
Yılmaz, Yusuf; Toraman, Ahmet Eren; Alp, Ceyda; Doğan, Zehra; Keklikkıran, Çağlayan; Stepanova, Maria; Younossi, Zobair (Wiley, 2022)Background Patients with non-alcoholic fatty liver disease (NAFLD) and more advanced fibrosis tend to have more impairment in their health-related quality of life and other patient-reported outcomes (PROs). Aim To assess ... -
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
Sun, Dan-Qin; Targher, Giovanni; Byrne, Christopher D.; Wheeler, David C.; Wong, Vincent Wai-Sun; Fan, Jian-Gao; Tilg, Herbert; Yuan, Wei-Jie; Wanner, Christoph; Gao, Xin; Long, Michelle T.; Kanbay, Mehmet; Nguyen, Mindie H.; Navaneethan, Sankar D.; Yılmaz, Yusuf; Huang, Yuli; Gani, Rino A.; Marzuillo, Pierluigi; Boursier, Jerome; Zhang, Huijie; Jung, Chan-Young; Chai, Jin; Valenti, Luca; Papatheodoridis, George; Musso, Giovanni; Wong, Yu-Jun; El-Kassas, Mohamed; Mendez-Sanchez, Nahum; Sookoian, Silvia; Pavlides, Michael; Duseja, Ajay; Holleboom, Adriaan G.; Shi, Junping; Chan, Wah-Kheong; Fouad, Yasser; Yang, Junwei; Treeprasertsuk, Sombat; Cortez-Pinto, Helena; Hamaguchi, Masahide; Romero-Gomez, Manuel; Al Mahtab, Mamun; Ocama, Ponsiano; Nakajima, Atsushi; Dai, Chunsun; Eslam, Mohammed; Wei, Lai; George, Jacob; Zheng, Ming-Hua (AME Publishing Company, 2023)Background: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In ...